Showing 1,801 - 1,820 results of 100,888 for search '(( 5 nn decrease ) OR ( 5 ((step decrease) OR (((we decrease) OR (a decrease)))) ))', query time: 1.62s Refine Results
  1. 1801

    Optical Effects of <i>S</i>-Oxidation and M<sup><i>n</i>+</sup> Binding in <i>meso</i>-Thienyl Dipyrrin Systems and of Stepwise Bromination of 4,4-Difluoro-8-(2,5-dibromo-3-thienyl... by Shin Hei Choi (2190841)

    Published 2008
    “…Treatment of 4,4-difluoro-8-(2,5-dibromo-3-thienyl)-4-bora-3<i>a</i>,4<i>a</i>-diaza-<i>s</i>-indacene with Br<sub>2</sub> gave red-shifted UV−vis absorption band features that grow with increasing dipyrrin bromination. …”
  2. 1802

    Optical Effects of <i>S</i>-Oxidation and M<sup><i>n</i>+</sup> Binding in <i>meso</i>-Thienyl Dipyrrin Systems and of Stepwise Bromination of 4,4-Difluoro-8-(2,5-dibromo-3-thienyl... by Shin Hei Choi (2190841)

    Published 2008
    “…Treatment of 4,4-difluoro-8-(2,5-dibromo-3-thienyl)-4-bora-3<i>a</i>,4<i>a</i>-diaza-<i>s</i>-indacene with Br<sub>2</sub> gave red-shifted UV−vis absorption band features that grow with increasing dipyrrin bromination. …”
  3. 1803
  4. 1804
  5. 1805
  6. 1806
  7. 1807

    FABP5 down regulation increases inflammation but decreases innate immunity in primary NHBE cells. by Fabienne Gally (260470)

    Published 2013
    “…<p><b>A.</b> CS exposure increases <i>P. aeruginosa</i> colony forming units (CFU) on FABP5 knocked down primary NHBE cells. …”
  8. 1808
  9. 1809

    Overexpression of FTH1P3 decreased the miR-224-5p expression. by Xiaoli Zheng (232806)

    Published 2017
    “…<p>(A) Elevated expression of FTH1P3 decreased the miR-224-5p expression in the MUM-2B cell. …”
  10. 1810
  11. 1811
  12. 1812
  13. 1813
  14. 1814
  15. 1815
  16. 1816
  17. 1817
  18. 1818

    Discovery of Novel [1,2,4]Triazolo[1,5‑<i>a</i>]pyrimidine Derivatives as Novel Potent S‑Phase Kinase-Associated Protein 2 (SKP2) Inhibitors for the Treatment of Cancer by Kaizhao Hu (15670612)

    Published 2024
    “…Pharmacological inhibition of Skp2 has exhibited promising antitumor activity. Herein, we present the design and optimization of a series of [1,2,4]triazolo[1,5-<i>a</i>]pyrimidine-based small molecules targeting Skp2. …”
  19. 1819

    Discovery of Novel [1,2,4]Triazolo[1,5‑<i>a</i>]pyrimidine Derivatives as Novel Potent S‑Phase Kinase-Associated Protein 2 (SKP2) Inhibitors for the Treatment of Cancer by Kaizhao Hu (15670612)

    Published 2024
    “…Pharmacological inhibition of Skp2 has exhibited promising antitumor activity. Herein, we present the design and optimization of a series of [1,2,4]triazolo[1,5-<i>a</i>]pyrimidine-based small molecules targeting Skp2. …”
  20. 1820

    Discovery of Novel [1,2,4]Triazolo[1,5‑<i>a</i>]pyrimidine Derivatives as Novel Potent S‑Phase Kinase-Associated Protein 2 (SKP2) Inhibitors for the Treatment of Cancer by Kaizhao Hu (15670612)

    Published 2024
    “…Pharmacological inhibition of Skp2 has exhibited promising antitumor activity. Herein, we present the design and optimization of a series of [1,2,4]triazolo[1,5-<i>a</i>]pyrimidine-based small molecules targeting Skp2. …”